1049026-36-9Relevant academic research and scientific papers
ACLY INHIBITORS AND USES THEREOF
-
Paragraph 00607, (2020/06/01)
The present invention provides compounds useful as inhibitors of ATP citrate lyase (ACLY), compositions thereof, and methods of using the same.
Design and synthesis of benzenesulfonamide derivatives as potent anti-influenza hemagglutinin inhibitors
Tang, Guozhi,Lin, Xianfeng,Qiu, Zongxing,Li, Wentao,Zhu, Lei,Wang, Lisha,Li, Shaohua,Li, Haodong,Lin, Wenbin,Yang, Mei,Guo, Tao,Chen, Li,Lee, Daniel,Wu, Jim Z.,Yang, Wengang
supporting information; experimental part, p. 603 - 607 (2011/10/09)
Structural optimization of salicylamide-based hemagglutinin (HA) inhibitor 1 resulted in the identification of cis-3-(5-hydroxy-1,3,3- trimethylcyclohexylmethylamino)benzenesulfonamide 28 and its derivatives as potent anti-influenza agents. The lead compo
SULFONAMIDE COMPOUNDS AND THE USE
-
Page/Page column 26, (2010/02/17)
The sulfoneamide compounds having the following Formula (1), which can be used as an effective component of a CaSR antagonizing agent useful for prophylaxis and/or treatment of bone disorders including osteoporosis and etc., are provided. The compounds have an excellent activity of promoting PTH secretion. In addition, the compounds are useful as an effective component of a medicament for the prophylaxis and/or treatment of bone disorders such as osteoporosis, bone fracture, hypoparathyroidism and the like.
NEW ARYLSULPHONYLGLYCINE DERIVATIVES, THE PREPARATION THEREOF AND THEIR USE AS MEDICAMENTS
-
Page/Page column 141-142, (2009/12/02)
The invention relates to substituted arylsulphonylglycine derivatives of general formula (I) wherein the groups Ra to Rf, A and Z are defined as in the specification and claims, which are suitable for preparing a pharmaceutical composition for the treatment of metabolic disorders, particularly type 1 or type 2 diabetes mellitus.
ARYLSULFONYLAMINOMETHYLPHOSPHONIC ACID DERIVATIVES, THE PREPARATION THEREOF AND THE USE THEREOF AS PHARMACEUTICAL COMPOSITIONS
-
Page/Page column 86, (2009/04/25)
The invention relates tosubstitutedarylsulphonylaminomethylphosphonic acid derivativesof general formula (I) wherein the groups Ra to Rf, A and Z are defined as mentioned in the specification and claims, which are suitable for preparinga medicament for the treatmentof metabolic disorders, particularlytype 1 or type 2 diabetesmellitus.
